1010 related articles for article (PubMed ID: 10383122)
61. Multiple GPI-anchored receptors control GDNF-dependent and independent activation of the c-Ret receptor tyrosine kinase.
Trupp M; Raynoschek C; Belluardo N; Ibáñez CF
Mol Cell Neurosci; 1998 May; 11(1-2):47-63. PubMed ID: 9608533
[TBL] [Abstract][Full Text] [Related]
62. The RET receptor tyrosine kinase: activation, signalling and significance in neural development and disease.
Mason I
Pharm Acta Helv; 2000 Mar; 74(2-3):261-4. PubMed ID: 10812967
[TBL] [Abstract][Full Text] [Related]
63. Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease.
Lapchak PA; Gash DM; Jiao S; Miller PJ; Hilt D
Exp Neurol; 1997 Mar; 144(1):29-34. PubMed ID: 9126148
[TBL] [Abstract][Full Text] [Related]
64. Human glial cell line-derived neurotrophic factor receptor alpha 4 is the receptor for persephin and is predominantly expressed in normal and malignant thyroid medullary cells.
Lindahl M; Poteryaev D; Yu L; Arumae U; Timmusk T; Bongarzone I; Aiello A; Pierotti MA; Airaksinen MS; Saarma M
J Biol Chem; 2001 Mar; 276(12):9344-51. PubMed ID: 11116144
[TBL] [Abstract][Full Text] [Related]
65. c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3K)-dependent pathway.
Encinas M; Tansey MG; Tsui-Pierchala BA; Comella JX; Milbrandt J; Johnson EM
J Neurosci; 2001 Mar; 21(5):1464-72. PubMed ID: 11222636
[TBL] [Abstract][Full Text] [Related]
66. Medium-throughput computer aided micro-island method to assay embryonic dopaminergic neuron cultures in vitro.
Planken A; Porokuokka LL; Hänninen AL; Tuominen RK; Andressoo JO
J Neurosci Methods; 2010 Dec; 194(1):122-31. PubMed ID: 20951734
[TBL] [Abstract][Full Text] [Related]
67. GDNF and ET-3 differentially modulate the numbers of avian enteric neural crest cells and enteric neurons in vitro.
Hearn CJ; Murphy M; Newgreen D
Dev Biol; 1998 May; 197(1):93-105. PubMed ID: 9578621
[TBL] [Abstract][Full Text] [Related]
68. PSPN/GFRalpha4 has a significantly weaker capacity than GDNF/GFRalpha1 to recruit RET to rafts, but promotes neuronal survival and neurite outgrowth.
Yang J; Lindahl M; Lindholm P; Virtanen H; Coffey E; Runeberg-Roos P; Saarma M
FEBS Lett; 2004 Jul; 569(1-3):267-71. PubMed ID: 15225646
[TBL] [Abstract][Full Text] [Related]
69. Identification of a surface for binding to the GDNF-GFR alpha 1 complex in the first cadherin-like domain of RET.
Kjaer S; Ibáñez CF
J Biol Chem; 2003 Nov; 278(48):47898-904. PubMed ID: 14514671
[TBL] [Abstract][Full Text] [Related]
70. Functional receptor for GDNF encoded by the c-ret proto-oncogene.
Trupp M; Arenas E; Fainzilber M; Nilsson AS; Sieber BA; Grigoriou M; Kilkenny C; Salazar-Grueso E; Pachnis V; Arumäe U
Nature; 1996 Jun; 381(6585):785-9. PubMed ID: 8657281
[TBL] [Abstract][Full Text] [Related]
71. Regulation of neural development by glial cell line-derived neurotrophic factor family ligands.
Enomoto H
Anat Sci Int; 2005 Mar; 80(1):42-52. PubMed ID: 15794130
[TBL] [Abstract][Full Text] [Related]
72. Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas.
Frisk T; Farnebo F; Zedenius J; Grimelius L; Höög A; Wallin G; Larsson C
Eur J Endocrinol; 2000 Jun; 142(6):643-9. PubMed ID: 10822229
[TBL] [Abstract][Full Text] [Related]
73. Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro.
Eggert K; Schlegel J; Oertel W; Würz C; Krieg JC; Vedder H
Neurosci Lett; 1999 Jul; 269(3):178-82. PubMed ID: 10454161
[TBL] [Abstract][Full Text] [Related]
74. Glial line-derived neurotrophic factor (GDNF): Biological activities.
W W
Folia Morphol (Warsz); 1999; 58(3):155-9. PubMed ID: 14663755
[TBL] [Abstract][Full Text] [Related]
75. Persephin, a novel neurotrophic factor related to GDNF and neurturin.
Milbrandt J; de Sauvage FJ; Fahrner TJ; Baloh RH; Leitner ML; Tansey MG; Lampe PA; Heuckeroth RO; Kotzbauer PT; Simburger KS; Golden JP; Davies JA; Vejsada R; Kato AC; Hynes M; Sherman D; Nishimura M; Wang LC; Vandlen R; Moffat B; Klein RD; Poulsen K; Gray C; Garces A; Johnson EM
Neuron; 1998 Feb; 20(2):245-53. PubMed ID: 9491986
[TBL] [Abstract][Full Text] [Related]
76. GDNF: a novel factor with therapeutic potential for neurodegenerative disorders.
Walton KM
Mol Neurobiol; 1999 Feb; 19(1):43-59. PubMed ID: 10321971
[TBL] [Abstract][Full Text] [Related]
77. Differences and developmental changes in the responsiveness of PNS neurons to GDNF and neurturin.
Forgie A; Doxakis E; Buj-Bello A; Wyatt S; Davies AM
Mol Cell Neurosci; 1999 Jun; 13(6):430-40. PubMed ID: 10383828
[TBL] [Abstract][Full Text] [Related]
78. Glial cell line-derived neurotrophic factor and neurturin inhibit neurite outgrowth and activate RhoA through GFR alpha 2b, an alternatively spliced isoform of GFR alpha 2.
Yoong LF; Too HP
J Neurosci; 2007 May; 27(21):5603-14. PubMed ID: 17522305
[TBL] [Abstract][Full Text] [Related]
79. GDNF family ligands trigger indirect neuroprotective signaling in retinal glial cells.
Hauck SM; Kinkl N; Deeg CA; Swiatek-de Lange M; Schöffmann S; Ueffing M
Mol Cell Biol; 2006 Apr; 26(7):2746-57. PubMed ID: 16537917
[TBL] [Abstract][Full Text] [Related]
80. Analysis of the retrograde transport of glial cell line-derived neurotrophic factor (GDNF), neurturin, and persephin suggests that in vivo signaling for the GDNF family is GFRalpha coreceptor-specific.
Leitner ML; Molliver DC; Osborne PA; Vejsada R; Golden JP; Lampe PA; Kato AC; Milbrandt J; Johnson EM
J Neurosci; 1999 Nov; 19(21):9322-31. PubMed ID: 10531437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
